Discoveries, Developments and Drugs in Retina

My Session Status

What:
Keynote Speaker | Invité.e d'honneur
When:
3:45 PM, Saturday 27 Jun 2020 (1 hour 25 minutes)
Where:
Vancouver Convention Centre (East Building) - Ballroom B
Theme:
Retina


LEARNING OBJECTIVES:

  • To do describe how novel developments in genetic therapy can be used to improve visual outcomes and visual quality of life in patients with inherited retinal dystrophies and degenerative disorders.
  • To identify and describe emerging data evaluating the risk of maculopathy with the use of systemic pentosan polysulfate and integrate proposed guidelines for risk mitigation into clinical practice.

CANMEDS ROLES: Medical Expert, Scholar

Sub Sessions

The Ophthalmologist's Changing Practice in the Era of Gene Therapy
3:45 PM - 4:10 PM | 25 minutes
Retina

Nancy Holekamp, MD
Keynote speaker
Q&A
4:20 PM - 4:25 PM | 5 minutes
Retina
Q&A
4:35 PM - 4:40 PM | 5 minutes
Retina
Q&A
4:50 PM - 4:55 PM | 5 minutes
Retina
Pentosan Maculopathy - Prevalence, Screening Guidelines and Spectrum of Disease
4:55 PM - 5:01 PM | 6 minutes
Retina

David Sarraf, MD
Keynote speaker

My Session Status

Send Feedback

Session detail
Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.
When enabled, you can choose to display attendee lists for individual sessions. Only attendees who have chosen to share their profile will be listed.
Enable to display the attendee list on this session's detail page. This change applies only to this session.

Changes here will affect all session detail pages unless otherwise noted